Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Boulware

Showing results (261-270 of 350) with videos related to

Pageof 35
Sort By:
Open Forum Infectious Diseases|February 16, 2026
Prevalence of CSF HIV VIRAL Escape and Associations With Neurocognitive Outcomes Among HIV-Associated Meningitis Survivors: A Cohort StudyLaura Nsangi, Gila Hale, Biyue Dai, et al.
Open Forum Infectious Diseases|March 19, 2026
Use of DOOR and Win-Ratio Analysis in a Secondary Evaluation of a Histoplasmosis Clinical TrialTarsila Vieceli, Biyue Dai, Diego R Falci, et al.
Open Forum Infectious Diseases|July 27, 2022
Association of Hyponatremia on Mortality in Cryptococcal Meningitis: A Prospective CohortLillian Tugume, Ann Fieberg, Kenneth Ssebambulidde, et al.
Journal of Neurovirology|August 1, 2021
Improvement in depressive symptoms after antiretroviral therapy initiation in people with HIV in Rakai, UgandaNoeline Nakasujja, Alyssa C Vecchio, Deanna Saylor, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|July 17, 2022
Cytomegalovirus viremia as a risk factor for mortality in HIV-associated cryptococcal and tuberculous meningitisCaleb P Skipper, Katherine Huppler Hullsiek, Fiona V Cresswell, et al.
The Lancet. Infectious Diseases|July 27, 2019
Adjunctive sertraline for HIV-associated cryptococcal meningitis: a randomised, placebo-controlled, double-blind phase 3 trialJoshua Rhein, Kathy Huppler Hullsiek, Lillian Tugume, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 27, 2018
Symptomatic Cryptococcal Antigenemia Presenting as Early Cryptococcal Meningitis With Negative Cerebral Spinal Fluid AnalysisKenneth Ssebambulidde, Ananta S Bangdiwala, Richard Kwizera, et al.
Open Forum Infectious Diseases|May 25, 2022
Noninvasive Testing and Surrogate Markers in Invasive Fungal DiseasesGeorge R Thompson, David R Boulware, Nathan C Bahr, et al.
Open Forum Infectious Diseases|July 26, 2024
Mid-Upper Arm Circumference Is a Strong Predictor of Mortality Among Ugandan Adults With HIV-Associated Cryptococcal Meningitis: A Prospective Cohort StudyGila Hale, Tessa Adzemovic, Kathy Huppler Hullsiek, et al.
The Lancet. Infectious Diseases|March 14, 2016
Efficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: an open-label dose-ranging studyJoshua Rhein, Bozena M Morawski, Kathy Huppler Hullsiek, et al.
Pageof 35

Showing results (261-270 of 350) with videos related to

Sort By:
Pageof 35
Open Forum Infectious Diseases|February 16, 2026
Prevalence of CSF HIV VIRAL Escape and Associations With Neurocognitive Outcomes Among HIV-Associated Meningitis Survivors: A Cohort StudyLaura Nsangi, Gila Hale, Biyue Dai, et al.
Open Forum Infectious Diseases|March 19, 2026
Use of DOOR and Win-Ratio Analysis in a Secondary Evaluation of a Histoplasmosis Clinical TrialTarsila Vieceli, Biyue Dai, Diego R Falci, et al.
Open Forum Infectious Diseases|July 27, 2022
Association of Hyponatremia on Mortality in Cryptococcal Meningitis: A Prospective CohortLillian Tugume, Ann Fieberg, Kenneth Ssebambulidde, et al.
Journal of Neurovirology|August 1, 2021
Improvement in depressive symptoms after antiretroviral therapy initiation in people with HIV in Rakai, UgandaNoeline Nakasujja, Alyssa C Vecchio, Deanna Saylor, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|July 17, 2022
Cytomegalovirus viremia as a risk factor for mortality in HIV-associated cryptococcal and tuberculous meningitisCaleb P Skipper, Katherine Huppler Hullsiek, Fiona V Cresswell, et al.
The Lancet. Infectious Diseases|July 27, 2019
Adjunctive sertraline for HIV-associated cryptococcal meningitis: a randomised, placebo-controlled, double-blind phase 3 trialJoshua Rhein, Kathy Huppler Hullsiek, Lillian Tugume, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 27, 2018
Symptomatic Cryptococcal Antigenemia Presenting as Early Cryptococcal Meningitis With Negative Cerebral Spinal Fluid AnalysisKenneth Ssebambulidde, Ananta S Bangdiwala, Richard Kwizera, et al.
Open Forum Infectious Diseases|May 25, 2022
Noninvasive Testing and Surrogate Markers in Invasive Fungal DiseasesGeorge R Thompson, David R Boulware, Nathan C Bahr, et al.
Open Forum Infectious Diseases|July 26, 2024
Mid-Upper Arm Circumference Is a Strong Predictor of Mortality Among Ugandan Adults With HIV-Associated Cryptococcal Meningitis: A Prospective Cohort StudyGila Hale, Tessa Adzemovic, Kathy Huppler Hullsiek, et al.
The Lancet. Infectious Diseases|March 14, 2016
Efficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: an open-label dose-ranging studyJoshua Rhein, Bozena M Morawski, Kathy Huppler Hullsiek, et al.
Pageof 35